Biomarkers: New Advances in Diabetic Nephropathy
Natural Product Communications,
Год журнала:
2025,
Номер
20(2)
Опубликована: Фев. 1, 2025
Diabetic
nephropathy
(DN)
is
the
leading
cause
of
uremia
and
clinical
mortality,
characterized
by
progressive
deterioration
kidney
structure
function
due
to
prolonged
exposure
hyperglycemia.
This
condition
often
necessitates
renal
replacement
therapy
for
patients
with
end-stage-renal-disease
(ESRD).
Consequently,
early
detection,
diagnosis,
treatment
DN
are
crucial
mitigate
disease
progression,
enhance
patient
outcomes,
maintain
a
good
quality
life.
Exploring
relevant
biomarkers
diagnosis
holds
significant
importance.
In
recent
years,
numerous
researchers
have
identified
various
novel
associated
diabetic
nephropathy,
which
critical
predicting
both
onset
progression
disease.
article
aims
provide
comprehensive
overview
related
DN.
Язык: Английский
Exploring the beneficial effect of gut microbiota metabolites on diabetic nephropathy via network pharmacology study
Weiguo Yao,
Jinlin Huo,
Kun Liu
и другие.
Scientific Reports,
Год журнала:
2025,
Номер
15(1)
Опубликована: Апрель 1, 2025
Diabetic
nephropathy
(DN)
is
one
of
the
severe
complications
diabetes,
current
treatment
against
DN
still
limited.
It
suggested
that
gut
microbiota
metabolites
will
be
a
promising
alternative
therapy
DN.
In
this
study,
we
explore
beneficial
effect
on
via
employing
network
pharmacology
study.
The
targets
were
screen
from
Similarity
Ensemble
Approach
(SEA)
and
Swiss
Target
Prediction
(STP).
acquired
disease
database.
intersecting
considered
crucial
targets.
Protein–Protein
Interaction
(PPI)
networks,
GO
function
KEGG
analysis
conducted
to
identify
core
target
key
signaling
pathway.
A
"Microbiota-Substrate-Metabolites-Targets"
was
built
metabolites.
Molecular
docking
employed
assess
binding
affinity
between
functional
results
indicated
mainly
enriched
in
oxidative
stress
inflammation.
PPARG,
AKT1,
IL6
JUN
top
4
regulating
Butyrate,
Acetate,
Indole
3-Indolepropionic
acid
had
effects
attenuating
displayed
good
toward
JUN.
Our
study
revealed
might
exert
by
multi-signaling
pathway
multi-targets.
This
work
offers
us
novel
insight
into
mechanism
perspective
benefits
Язык: Английский
Novel Metabolites Associated with Decreased GFR in Finnish Men: A 12-Year Follow-Up of the METSIM Cohort
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(18), С. 10044 - 10044
Опубликована: Сен. 18, 2024
Identification
of
the
individuals
having
impaired
kidney
function
is
essential
in
preventing
complications
this
disease.
We
measured
1009
metabolites
at
baseline
study
10,159
Finnish
men
METSIM
cohort
and
associated
with
an
estimated
glomerular
filtration
rate
(eGFR).
A
total
7090
participated
12-year
follow-up
study.
Non-targeted
metabolomics
profiling
was
performed
Metabolon,
Inc.
(Morrisville,
NC,
USA)
on
EDTA
plasma
samples
obtained
after
overnight
fasting.
applied
liquid
chromatography
mass
spectrometry
(LC-MS/MS)
to
identify
(the
Metabolon
DiscoveryHD4
platform).
association
analyses
between
eGFR
using
linear
regression
adjusted
for
confounding
factors.
found
108
significantly
a
decrease
eGFR,
28
them
were
novel,
including
12
amino
acids,
8
xenobiotics,
5
lipids,
1
nucleotide,
peptide,
partially
characterized
molecule.
The
most
significant
associations
five
N-acetylmethionine,
N-acetylvaline,
gamma-carboxyglutamate,
3-methylglutaryl-carnitine,
pro-line.
identified
novel
decreased
cohort.
These
findings
provide
insights
into
role
metabolic
pathways
involved
decline
function.
Язык: Английский
Lower Free Thyroxine Levels Are Associated with Diabetic Kidney Disease in Males with Type 2 Diabetes Mellitus: An Observational Cross-Sectional Study
Biomedicines,
Год журнала:
2024,
Номер
12(10), С. 2370 - 2370
Опубликована: Окт. 17, 2024
:
We
aimed
to
explore
the
correlation
between
thyroid
function
and
diabetic
kidney
disease
(DKD)
in
patients
with
type
2
diabetes
mellitus
(T2DM).
Язык: Английский